Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02268786 · ClinicalTrials.gov registry record · NA
Single Embryo TrAnsfeR of Euploid Embryo
A NA study, sponsored by Illumina.
- Completed
- Registry status
- NA
- Development phase
- 661
- Enrollment target
NCT02268786 is a NA study that has completed, run by Illumina. The registered enrollment target is 661 participants.
The verdict
NCT02268786, a NA study, has completed, sponsored by Illumina.
- COMPLETED
- Registry status
- NA
- Development phase
- 661 participants
- Enrollment target
Study Summary
The purpose of the current study is to evaluate the effect of preimplantation genetic screening (PGS) by next generation sequencing (NGS) compared to standard morphological assessment of embryos on pregnancy rates through a randomized controlled trial (RCT). All embryos will be vitrified and a single embryo transfer (SET) will be performed with either screened or unscreened embryos depending on randomization.
Interventions
- OTHER Preimplantation Genetic Screening by NGS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 661 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02268786
The ClinicalTrials.gov registry entry for NCT02268786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 661 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Illumina, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preimplantation Genetic Screening by NGS is the first listed.
NCT02268786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02268786 about?
NCT02268786 is a clinical study titled "Single Embryo TrAnsfeR of Euploid Embryo". The purpose of the current study is to evaluate the effect of preimplantation genetic screening (PGS) by next generation sequencing (NGS) compared to standard morphological assessment of embryos on pregnancy rates through a randomized controlled trial (RCT). All embryos will be vitrified and a singl...
What is the current status of trial NCT02268786?
This trial is currently completed. It is a NA study. The enrollment target is 661 participants. The study started on 2014-09. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02268786?
The interventions under investigation include: Preimplantation Genetic Screening by NGS (OTHER).
Who is sponsoring clinical trial NCT02268786?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.